Phone
+39 010 2896 983
Address
Via Morego, 30 16163 Genova
Research center
CCT@Morego
Biografia
All Publications
2024
Bagnolini G., Poppi L., Previtali V., Ferrandi G., Rinaldi F., Girotto S., Hirsch A.K.H., Roberti M., Cavalli A.
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery
National Congress of the Italian Chemistry Society 2024
Poster
Conference
2024
Brindani N., Vuong L.M., La Serra M.A., Salvador N., Menichetti A., Acquistapace I.M., Ortega J.A., Veronesi M., Bertozzi S.M., Summa M., Girotto S., Bertorelli R., Armirotti A., Ganesan A.K., De Vivo M.
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy
Journal of Medicinal Chemistry
Article
Journal
2024
Balboni B., Marotta R., Rinaldi F., Milordini G., Varignani G., Girotto S., Cavalli A.
Human full-length RAD52 at 2.2 Å resolution: an integrative structural biology study
Communications Biology
Article
Journal
2024
Romeo E., Saccoliti F., Andonaia A., Allegretta C., Laselva O., Falchi F., Occello R., Liessi N., Armirotti A., Girotto S., Pastorino C., Pedemonte N., Bandiera T., Bertozzi F.
Mechanism of action and binding site characterization of corrector ARN23765 via Photo-Affinity Labeling (PAL) approach in live cells
19th ECFS Basic Science Conference
Poster
Conference
2023
Myers S. H., Poppi L., Rinaldi F., Veronesi M., Ciamarone A., Previtali V., Bagnolini G., Schipani F., Ortega Martínez J. A., Girotto S., Di Stefano G., Farabegoli F., Walsh N., De Franco F., Roberti M., Cavalli A.
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer
European Journal of Medicinal Chemistry
Colleagues of Structural Biophysics
